• Drug discovery entrepreneur and scientist-executive with prominent track record in pharma and biotech industry.• Pioneer in peptide mimetics technology and rational drug design.• Co-founder of Provid Pharmaceuticals. Responsible for strategic direction and leadership of multiple programs for internal R&D and for clients. • Extensive experience in business development, licensing, and in creation of a business model combining drug discovery services with internal projects to provide both ongoing revenue and value. • Key scientific achievements include the discovery of MHC class II inhbitors for the treatment of autoimmune disease (e.g., PV-267 for multiple sclerosis), contributions to the field of receptor modeling, the design of piquindone (antipsychotic) and cognition-enhancing drugs. • Inventions and grants: 60 US patents/applications and 10 funded government and foundation grants.
Listed skills include Medicinal Chemistry, Drug Discovery, Chemistry, Drug Design, and 18 others.